Wang, H., Chu, J., Zhao, Y., Tang, H., Wang, L., Zhou, M., . . . Yao, Z. (2020). A Trial of the Safety and Efficacy of Chemotherapy Plus Anlotinib vs Chemotherapy Alone as Second- or Third-Line Salvage Treatment for Advanced Non-Small Cell Lung Cancer. Cancer Manag Res.
Citação norma ChicagoWang, Hai-ying, Jun-feng Chu, Yan Zhao, Hong Tang, Li-li Wang, Meng-qiang Zhou, Zheng Yan, Yan-yan Liu, and Zhi-hua Yao. "A Trial of the Safety and Efficacy of Chemotherapy Plus Anlotinib Vs Chemotherapy Alone As Second- or Third-Line Salvage Treatment for Advanced Non-Small Cell Lung Cancer." Cancer Manag Res 2020.
Citação norma MLAWang, Hai-ying, et al. "A Trial of the Safety and Efficacy of Chemotherapy Plus Anlotinib Vs Chemotherapy Alone As Second- or Third-Line Salvage Treatment for Advanced Non-Small Cell Lung Cancer." Cancer Manag Res 2020.